Literature DB >> 9251630

Watchful waiting or drug therapy for benign prostatic hyperplasia?

D E Neal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9251630     DOI： 10.1016/s0140-6736(05)63382-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.

Authors:  Fatih Hizli; M Cemil Uygur
Journal:  Int Urol Nephrol       Date:  2007-01-04       Impact factor: 2.370

2.  Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.

Authors:  Tong Cai; Yuanshan Cui; Shaoxia Yu; Qian Li; Zhongbao Zhou; Zhenli Gao
Journal:  Am J Mens Health       Date:  2020 Mar-Apr

3.  The shape of the urine stream--from biophysics to diagnostics.

Authors:  Andrew P S Wheeler; Samir Morad; Noor Buchholz; Martin M Knight
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.